Cargando…
Thiazolidinediones lower the risk of pneumonia in patients with type 2 diabetes
INTRODUCTION: We conducted this study to compare the risk of pneumonia between thiazolidinedione (TZD) use and nonuse in persons with type 2 diabetes (T2D). METHODS: We identified 46,763 propensity-score matched TZD users and nonusers from Taiwan’s National Health Insurance Research Database between...
Autores principales: | Yen, Fu-Shun, Wei, James Cheng-Chung, Hung, Yu-Tung, Hsu, Chung Y., Hwu, Chii-Min, Hsu, Chih-Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981669/ https://www.ncbi.nlm.nih.gov/pubmed/36876083 http://dx.doi.org/10.3389/fmicb.2023.1118000 |
Ejemplares similares
-
Thiazolidinedione Use in Individuals With Type 2 Diabetes and Chronic Obstructive Pulmonary Disease
por: Yen, Fu-Shun, et al.
Publicado: (2021) -
Liver‐related long‐term outcomes of thiazolidinedione use in persons with type 2 diabetes
por: Yen, Fu‐Shun, et al.
Publicado: (2020) -
Metformin use and the risk of bacterial pneumonia in patients with type 2 diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2022) -
Metformin and the Risk of Chronic Urticaria in Patients with Type 2 Diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2022) -
Persons with type 2 diabetes and high insulin persistence were associated with a lower risk of mortality: A nationwide retrospective cohort study
por: Yen, Fu‐Shun, et al.
Publicado: (2020)